Company Filing History:
Years Active: 1997-2014
Title: Innovations by Inventor Alexandra Miller
Introduction
Alexandra Miller is a notable inventor based in Hyattsville, MD (US). She has made significant contributions to the field of medical science, particularly in the assessment and treatment of radiation injuries and cancer therapies. With a total of 2 patents, her work showcases innovative approaches to critical health challenges.
Latest Patents
Miller's latest patents include "Biomarker panels for assessing radiation injury and exposure" and "Monoterpenes, sesquiterpenes and diterpenes as cancer therapy." The first patent provides methods and kits for assessing radiation injury by measuring levels of protein biomarkers and correlating them with radiation exposure. This invention aims to assist clinicians in accurately determining treatment protocols based on individual assessments. The second patent focuses on cancer treatment methods that involve administering selected terpenes to mammals with various types of cancer, including prostate and colon cancer. This innovative approach also includes methods for sensitizing cancer to radiation and inhibiting the growth of cancer cells.
Career Highlights
Throughout her career, Miller has worked with esteemed organizations such as the United States of America as represented by the Department of Health and the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. Her work in these institutions has allowed her to contribute to significant advancements in medical research and treatment methodologies.
Collaborations
Miller has collaborated with notable professionals in her field, including Charles E. Myers and Jane B. Trepel. These collaborations have further enhanced her research and development efforts, leading to impactful innovations.
Conclusion
Alexandra Miller's contributions to medical science through her patents and collaborations highlight her role as a pioneering inventor. Her innovative approaches to assessing radiation exposure and treating cancer demonstrate the potential for significant advancements in healthcare.